Healthy, No Evidence of Disease
34
0
0
25
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.7%
5 terminated out of 34 trials
83.3%
-3.2% vs benchmark
6%
2 trials in Phase 3/4
20%
5 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (34)
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
Hepatobiliary Tumors Tissue Samples Acquisition
Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination
Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities
Light-Scattering Spectroscopy for Detection of Breast Cancer
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
Evaluation of SAMe for Hot Flashes
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Effects of Garlic Supplements on Opioids in Healthy Volunteers
Diindolylmethane in Preventing Cancer in Healthy Volunteers
Bowman-Birk Inhibitor Concentrate in Healthy Men
Diindolylmethane in Healthy Volunteers
Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Lycopene in Healthy Male Participants